Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Aduro Biotech (ADRO)

Aduro Biotech (ADRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Aduro Biotech 740 HEINZ AVENUE BERKELEY CA 94710 USA

www.aduro.com P: 510-848-4400

Description:

Aduro Biotech, Inc. is an immunotherapy company. The Company develops technology and vaccines for the treatment of cancer and mesothelin-expressing tumors. Its product pipeline includes CRS-207, ADU-623, ADU-214, ADU-741, CDN and STINGVAX which are in different clinical trial. Aduro Biotech, Inc. is based in BERKELEY, United States.

Key Statistics

Overview:

Market Capitalization, $K 236,614
Shares Outstanding, K 16,212
Annual Sales, $ 17,260 K
Annual Net Income, $ -82,370 K
Last Quarter Sales, $ 5,570 K
Last Quarter Net Income, $ -16,620 K
60-Month Beta 0.40
% of Insider Shareholders 5.90%
% of Institutional Shareholders 49.93%
Float, K 15,255
% Float 94.10%

Growth:

1-Year Return 189.01%
3-Year Return -68.44%
5-Year Return -87.25%
5-Year Revenue Growth 28.90%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 11/05/20
Earnings Per Share ttm -4.00
EPS Growth vs. Prev Qtr -133.33%
EPS Growth vs. Prev Year 8.70%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-5 on 10/02/20

ADRO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -101.73%
Return-on-Assets % -22.35%
Profit Margin % -477.23%
Debt/Equity 0.00
Price/Sales 13.16
Price/Cash Flow N/A
Price/Book 5.08
Book Value/Share 2.88
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar